Bradykinin Release in Acute Pancreatitis
Author Information
Author(s): P. Jönsson, K. Ohlsson
Primary Institution: Department of Surgical Pathophysiology, University Hospital MAS, Lund University, Malmö, Sweden
Hypothesis
The release of bradykinin in the pancreatic gland is more profuse during taurocholate-induced pancreatitis than during caerulein-induced pancreatitis.
Conclusion
Severe pancreatitis is associated with extensive release of bradykinin within the gland, likely contributing to tissue damage.
Supporting Evidence
- Bradykinin levels were significantly elevated in necrotic pancreatitis compared to controls.
- Three rats in the taurocholate group died during the study.
- Microdialysis was used to directly measure bradykinin release in the pancreas.
Takeaway
This study looked at how a substance called bradykinin is released in the pancreas during two types of inflammation. It found that more bradykinin is released when the inflammation is more severe.
Methodology
The study used microdialysis to measure bradykinin levels in the pancreas of rats with two types of induced pancreatitis.
Limitations
The study was conducted on a small number of rats and may not fully represent human conditions.
Participant Demographics
Adult Wistar rats of both sexes, weighing 205-260g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website